+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

From
Migraine Drugs Market 2024-2028 - Product Thumbnail Image

Migraine Drugs Market 2024-2028

  • Report
  • November 2023
  • 168 Pages
  • Global
From
Sickle Cell Disease Treatment Market Report 2025 - Product Thumbnail Image

Sickle Cell Disease Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Paroxysmal Nocturnal Hemoglobinuria (PNH) Market Report 2025 - Product Thumbnail Image

Paroxysmal Nocturnal Hemoglobinuria (PNH) Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Neutropenia Treatment Market - Global Forecast 2025-2032 - Product Thumbnail Image

Neutropenia Treatment Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 182 Pages
  • Global
From
From
Paroxysmal Nocturnal Haemoglobinuria - Pipeline Insight, 2025 - Product Thumbnail Image

Paroxysmal Nocturnal Haemoglobinuria - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
Chemotherapy Induced Anemia Market - Global Forecast 2025-2032 - Product Thumbnail Image

Chemotherapy Induced Anemia Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 197 Pages
  • Global
From
From
From
Loading Indicator